Industry
Drug Manufacturers - Specialty & Generic
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also Xepi, a prescription cream for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Loading...
Open
0.88
Mkt cap
4.9M
Volume
380K
High
0.93
P/E Ratio
-0.33
52-wk high
4.32
Low
0.86
Div yield
N/A
52-wk low
0.61
Portfolio Pulse from Benzinga Insights
October 14, 2024 | 8:31 pm
Portfolio Pulse from Benzinga Newsdesk
October 14, 2024 | 2:31 pm
Portfolio Pulse from Benzinga Newsdesk
October 07, 2024 | 4:04 pm
Portfolio Pulse from Benzinga Newsdesk
October 07, 2024 | 12:46 pm
Portfolio Pulse from Avi Kapoor
August 19, 2024 | 9:18 am
Portfolio Pulse from Benzinga Newsdesk
August 16, 2024 | 1:49 pm
Portfolio Pulse from Benzinga Newsdesk
August 15, 2024 | 2:14 pm
Portfolio Pulse from Benzinga Newsdesk
August 14, 2024 | 8:22 pm
Portfolio Pulse from Benzinga Newsdesk
June 24, 2024 | 12:33 pm
Portfolio Pulse from Benzinga Newsdesk
June 24, 2024 | 12:31 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.